DIMETHYL-(6-METHYL-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-AMINE Chemical Properties

Melting point:

134 - 139°C

Density 

1.07±0.1 g/cm3(Predicted)

storage temp. 

Sealed in dry,Room Temperature

solubility 

Chloroform (Slightly), Methanol (Slightly)

pka

8.30±0.28(Predicted)

form 

Solid

color 

White to Pale Yellow

DIMETHYL-(6-METHYL-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-AMINE Usage And Synthesis

Synthesis

Step (i): Preparation of N,N-dimethyl-1-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)methylamine (8). Under stirring, 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine (200 g, 0.92 mol) was dissolved in acetic acid (985 mL). The reaction mixture was cooled to 0-5 °C and 40% aqueous dimethylamine (157 g, 1.39 mol) was slowly added followed by paraformaldehyde (36.11 g, 1.20 mol). The reaction mixture was stirred at 50-55°C for 3-4 hours, followed by removal of acetic acid under reduced pressure. Water (1.5 l) was added, the filtrate was filtered through a diatomaceous earth pad and the filtrate was alkalized to pH 8.0-8.5 by dropwise addition of 30% sodium hydroxide solution. filtration afforded an off-white solid, which was washed sequentially with water (500 ml) and hexane (200 ml). The solid was dried to constant weight in an oven to give 230 g of N,N-dimethyl-1-(6-methyl-2-(p-tolyl)imidazo[1,2-a]pyridin-3-yl)methylamine (8) in 91.6% yield and 93.5% purity. Melting point range: 137.9-141.5 °C. IR spectrum (cm^-1): 2944, 2809, 2761, 1502, 1454, 1389, 1018, 829, 799. 1H NMR (400 MHz, CDCl3): δ 2.25 (s, 6H), 2.36 (s, 3H), 2.40 (s, 3H), 3.84 (s, 2H), 7.04 (dd, J = 9.1 Hz, J = 1.6 Hz, 1H), 7.25 (d, J = 7.9 Hz, 2H), 7.52 (d, J = 9.1 Hz, 1H), 7.69 (d, J = 8.0 Hz, 2H), 8.10 (s, 1H). Mass spectrum (m/z): 280.4 (M + H)+.

References

[1] Patent: WO2009/7995, 2009, A1. Location in patent: Page/Page column 11; 13-14; 15-17
[2] Farmaco, 1991, vol. 46, # SUPPL. 1, p. 277 - 288
[3] Acta Poloniae Pharmaceutica - Drug Research, 2001, vol. 58, # 1, p. 43 - 52
[4] Patent: US2007/27180, 2007, A1. Location in patent: Page/Page column title page; sheet 1; 6

DIMETHYL-(6-METHYL-2-P-TOLYL-IMIDAZO[1,2-A]PYRIDIN-3-YLMETHYL)-AMINE(106961-33-5)Related Product Information

• TERT-BUTYL DIAZOACETATE
• Zolpidem Impurity 64
• Zolpidem-d6 Phenyl-4-carboxylic Acid
• Zolpidem 6-Carboxylic Acid Methyl Ester
• Zolpidem Phenyl-4-carboxylic Acid Ethyl Ester-d6
• 2-[4-(Ethoxycarbonyl)phenyl]-6-methyl-imidazo[1,2-a]pyridine
• Zolpidem Phenyl-4-carboxylic Acid
• 6-(Methoxycarbonyl)-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetic Acid,
• Zolpidem 6-Carboxylic Acid
• 4-methyl-N-[3,4,6-trideuterio-5-(trideuteriomethyl)pyridin-2-yl]benzamide
• Zolpidem Impurity 18
• Zolpidem Phenyl-4-carboxylic Acid Ethyl Ester
• 6-(Methoxycarbonyl)-2-(4-methylphenyl)imidazo[1,2-a]pyridine
• 6-Methyl-2-(4-Methylphenyl)-α-oxo-iMidazo[1,2-a]pyridine-3-acetic Acid Ethyl Ester
• Zolpidem-d6 6-Carboxylic Acid
• 2-[4-(Ethoxycarbonyl)phenyl]-6-methyl-imidazo[1,2-a]pyridine-3-acetic Acid
• N,N-dimethyl-2-oxo-2-[5,7,8-trideuterio-2-(4-methylphenyl)-6-(trideuteriomethyl)imidazo[1,2-a]pyridin-3-yl]acetamide
• Zolpidem-d6 6-Carboxylic Acid Methyl Ester